Health Condition 1: D509- Iron deficiency anemia, unspecified
Conditions
Interventions
Intervention1: Heme Iron
Polypeptide tablet: Oral 12 MG heme iron polypeptide tablet is a new type of iron preparation which is derived directly from hemoglobin hence is metabolised faster with lesse
Sponsors
Dr Arshiya Shaikh
Eligibility
Inclusion criteria
Inclusion criteria: All children between 1 year to 18 years with Iron Deficiency Anemia
Exclusion criteria
Exclusion criteria: 1. Patients who have received blood transfusion in the last three months 2. Patients who received iv Iron in the last one month 3. Patients who have malabsorption syndrome and inflammatory bowel disease 4. Patients who suffer from chronic blood loss like portal hypertension, anastomosis leak from surgical site, hemorrhoids, polyp, etc 5. Patients not consenting for study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Increase in hemoglobin with heme Iron polypeptide in comparison to Ferrous sulphate in children in Iron Deficiency AnemiaTimepoint: After 84 days of intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Relation between heme Iron polypeptide & Ferrous sulphate on hepcidin levelsTimepoint: After 24 hours of initiating intervention;Gastro intestinal side effects in both groups of heme Iron polypeptide & Ferrous sulphateTimepoint: Every week after starting intervention till 84 days | — |
Countries
India
Contacts
Public ContactDr Abhilasha Sampagar
KAHER Jawaharlal Nehru Medical College Belgaum
Outcome results
None listed